Financials

  • Market Capitalization 8.98 B
  • Employee 1 094
  • Founded 1998
  • CEO -
  • Website www.glaukos.com
  • Headquarter Delaware, United States
  • FIGI BBG000WG2LQ1
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-32.62
Price to sales ratio
11.22

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
855
PODD
Insulet Corporation - Common Stock
162.06 USD+0.48%-1.08%+8.60%-44.68%11.23 B USD
873
GMED
Globus Medical, Inc. Class A Common Stock
79.72 USD+2.05%-2.05%+1.13%+37.73%10.82 B USD
976
BRKR
Bruker Corporation - Common Stock
58.97 USD-1.81%-3.74%+7.69%+35.19%8.98 B USD
1036
BIO
Bio-Rad Laboratories, Inc. Class A Common Stock
297.56 USD+0.48%-0.36%+2.96%-11.63%7.96 B USD

Frequently asked questions about Glaukos Corporation Common Stock

What is the Glaukos Corporation Common Stock stock price today?

The current price of Glaukos Corporation Common Stock (GKOS) is 152.87. Over the past 24 hours, the stock has changed by +0.07%. Follow the GKOS chart for real-time price dynamics.

What is the stock ticker of Glaukos Corporation Common Stock?

Glaukos Corporation Common Stock trades under the ticker GKOS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Glaukos Corporation Common Stock stock going up?

GKOS has changed by +2.60% over the last week, +19.39% over the last month, and +46.12% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Glaukos Corporation Common Stock net income for the last quarter?

Glaukos Corporation Common Stock reported net income of -19.78 M for the last quarter. The previous quarter showed -133.66 M, which means net income changed by +85.20%.

How many employees does Glaukos Corporation Common Stock have?

As of the latest available data, Glaukos Corporation Common Stock has 1 094 employees. Workforce size can provide additional context about the company's scale and operations.

What is Glaukos Corporation Common Stock EBITDA?

Glaukos Corporation Common Stock EBITDA is -8.06 M, and its EBITDA margin is -5.35%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Glaukos Corporation Common Stock stock?

You can buy Glaukos Corporation Common Stock (GKOS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Glaukos Corporation Common Stock stock?

Investing in Glaukos Corporation Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GKOS chart and related analysis on metatrader.com as part of your research.

News